Scores by kind of claim
Each kind of claim is scored on its own, out of 100: the share that held up, with the range it likely falls in. Fewer resolved claims give a wider range.
-
Factual claims
Statements about the present or the past, checked against the record: did they hold up?
72 65 79 -
Predictions
Statements about events outside the person's control, checked once they fell due: did they come true?
66 54 78 -
Promises
Commitments to the person's or organisation's own future action, with something to deliver: was it delivered?
Insufficient record: 1 promise resolved, 5 needed for a score.
All types combined: 71 (likely 64 to 77, high confidence), from 79 claims: 60 factual claims, 19 predictions. It mixes kinds of claim in different proportions for different people, so compare people kind by kind.
Balaji Srinivasan's claims
37 claims
“Peter Thiel called it five years ago.”
Balaji Srinivasan, author of X post 31 March 2020 Post by @balajis on X, 2020-03-31 (X)
Peter Thiel had warned about biomedical red tape about five years before March 2020.
Mostly true True in substance, wrong in a detail.
What would count as true or false
True: a dated record from about 2013-2017 (roughly five years before March 2020) shows Peter Thiel warning that FDA or biomedical regulation is too restrictive, in a way that expressly anticipated problems in an epidemic or health emergency. Mostly true: Thiel publicly argued in that window that biomedical red tape (e.g. the FDA) should be cut back, but without tying it specifically to pandemics, or the date is a year or two outside the window. Mixed: Thiel made such criticisms, but only well outside the window or only in passing. Mostly false: Thiel's recorded statements on the subject are only loosely related, such as general anti-regulation remarks with no biomedical focus. False: there is no such statement by Thiel, or the record shows he took the opposite position.
Evidence
- Donald Trump’s ‘shadow president’ in Silicon Valley Politico · 28 February 2017
“He expounded on that view in a 2015 interview with The Washington Post in which he aired his concern that “the FDA is too restrictive,” that “pharmaceutical sales are way too bureaucratic,””
- Peter Thiel and the FDA Closer Readings (WordPress blog) · 23 March 2015
“However, the matter Thiel kept returning to was the FDA’s regulatory approval process and how it limits the potential social gains from greater innovation in the health space.”
- Peter Thiel and the FDA Closer Readings (WordPress blog) · 23 March 2015
“Conversely he argues for less emphasis on the efficacy of the drug but not a reduction in the safety standard expected.”
Reasoning
Politico (E1) reports that in a 2015 Washington Post interview Thiel said "the FDA is too restrictive" and that pharmaceutical sales are "way too bureaucratic". A March 2015 blog post (E2, E3) says Thiel kept coming back to how the FDA's approval process limits health innovation, and that he wanted less emphasis on proving efficacy. Both are dated about five years before March 2020, but neither shows Thiel connecting his criticism to an epidemic or health emergency. Under the criteria that makes the claim mostly true rather than true.
Cite this claim
Balaji Srinivasan, “Peter Thiel had warned about biomedical red tape about five years before March 2020.” (said 31 March 2020). Verdict: mostly true. Reliability API, claim c_3b2c3f03d259, method 0.1.0+c876030c. https://epistacklabs.com/claims/c_3b2c3f03d259
Claims without a verdict
- Unresolvable 148
- Not yet due 21
- Own records only 2
- Not researched 227
- Not checkable 1,091
Is a verdict here wrong, or do you speak for Balaji Srinivasan? Reply on the claim's own page, with the form at its foot (how replies work). Verdicts are made automatically; how verdicts and scores are made.